|
Volumn , Issue 1, 2003, Pages 40-44
|
Adoptive immunotherapy for malignant tumors
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RECOMBINANT INTERFERON;
RECOMBINANT INTERLEUKIN 2;
ANTINEOPLASTIC AGENT;
INTERFERON;
INTERLEUKIN 2;
ADOPTIVE IMMUNOTHERAPY;
ARTICLE;
CANCER;
CANCER IMMUNOTHERAPY;
COLORECTAL CANCER;
CYTOLYSIS;
HUMAN;
KIDNEY CANCER;
LYMPHOKINE ACTIVATED KILLER CELL;
LYMPHOMA;
MELANOMA;
CELL CULTURE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
FEMALE;
IMMUNOLOGY;
LYMPHOCYTE SUBPOPULATION;
MALE;
METHODOLOGY;
MORTALITY;
MULTIMODALITY CANCER THERAPY;
NEOPLASM;
RESEARCH;
REVIEW;
TIME;
TRANSPLANTATION;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
IMMUNOTHERAPY, ADOPTIVE;
INTERFERONS;
INTERLEUKIN-2;
KILLER CELLS, LYMPHOKINE-ACTIVATED;
LYMPHOCYTE SUBSETS;
MALE;
NEOPLASMS;
RESEARCH;
TIME FACTORS;
TUMOR CELLS, CULTURED;
|
EID: 0037264827
PISSN: 08696047
EISSN: 24143545
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (50)
|